The repair of DNA damage in tumour cells partially offset the therapeutic effect of radiotherapy, and combination therapy with radiotherapy, anti-PD-L1, and DNA repair inhibitors has been studied in HCC. The gene discussed is CD274; the disease is hepatocellular carcinoma.